Home > PS Ratio > CONCORD BIOTECH

CONCORD BIOTECH
PS (Price/Sales) Ratio

The Current P/S Ratio of CONCORD BIOTECH is 10.82.

Share Price ₹1,163.7Feb 03,2026
Market Cap ₹12,171.8 Cr
Sales-TTM₹1,125.2 CrTTM-Consolidated Results
Price/Sales10.82xCalculated as Market Cap/Sales
Explore Stock Analytics
AD     Remove this Ad
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals

Definition & Calculation of PS (Price/Sales) ratio of CONCORD BIOTECH

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of CONCORD BIOTECH is calculated as :

Current Market Cap [ ₹12,171.8 Cr] as on Feb 03,2026

(/) Sales [ ₹1,125.2 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 10.82x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for CONCORD BIOTECH , the investors are currently willing to pay '10.82 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of CONCORD BIOTECH !

The chart below summarizes the trend in P/S Ratio of CONCORD BIOTECH over the last five years.

Historical PS (Price/Sales) ratio chart of CONCORD BIOTECH


PS Ratio Performance Analysis for CONCORD BIOTECH

- CONCORD BIOTECH 's latest p/e ratio is 10.82x.

- CONCORD BIOTECH 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 6.05x.

- CONCORD BIOTECH 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, CONCORD BIOTECH 's p/e ratio peaked in Mar2024 at 15.66x.

- CONCORD BIOTECH 's p/e ratio hit its five-year low in Mar2023 of 0x.


How does CONCORD BIOTECH 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
CONCORD BIOTECH 1,125.210.8212,171.8
SUN PHARMACEUTICAL INDUSTRIES LTD56,809.17.19408,559.0
DIVIS LABORATORIES LTD10,029.016.44164,827.0
CIPLA LTD28,351.13.77106,825.0
TORRENT PHARMACEUTICALS LTD12,248.011.18136,942.0
DR REDDYS LABORATORIES LTD34,682.22.97103,077.0
MANKIND PHARMA LTD13,914.16.4088,996.6
ZYDUS LIFESCIENCES LTD24,493.93.7190,857.9
LUPIN LTD24,750.74.0499,911.5
AUROBINDO PHARMA LTD32,514.52.1971,215.0
ABBOTT INDIA LTD6,714.48.5057,096.1

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs CONCORD BIOTECH 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.19x
Max industry PS 16.44x
Median industry PS 6.40x
Average industry PS 7.02x



You may also like the below Video Courses